Your browser doesn't support javascript.
loading
Immunotherapy for liposarcoma: emerging opportunities and challenges.
Song, Zhengqing; Lu, Lili; Gao, Zixu; Zhou, Qiwen; Wang, Zhiming; Sun, Lei; Zhou, Yuhong.
Afiliación
  • Song Z; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Lu L; Biotherapy Centre, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Gao Z; Department of Plastic Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Zhou Q; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Wang Z; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Sun L; Department of Medical Oncology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Zhou Y; Institute of Developmental Biology and Molecular Medicine, Fudan University, Shanghai, 200032, China.
Future Oncol ; 18(30): 3449-3461, 2022 Sep.
Article en En | MEDLINE | ID: mdl-36214331
Liposarcoma is a rare type of malignant tumor with no effective treatment. Immunotherapy is a new kind of treatment that functions by activating the immune system to kill tumors cells. It has gained significant progress in other cancer types. This review discusses its exploration and application in liposarcoma.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Vacunas contra el Cáncer / Virus Oncolíticos / Liposarcoma Límite: Humans Idioma: En Revista: Future Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Vacunas contra el Cáncer / Virus Oncolíticos / Liposarcoma Límite: Humans Idioma: En Revista: Future Oncol Año: 2022 Tipo del documento: Article País de afiliación: China